These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34895729)

  • 1. Orbital Radiation for Thyroid Eye Disease: A Report by the American Academy of Ophthalmology.
    Sobel RK; Aakalu VK; Vagefi MR; Foster JA; Tao JP; Freitag SK; Wladis EJ; McCulley TJ; Yen MT
    Ophthalmology; 2022 Apr; 129(4):450-455. PubMed ID: 34895729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced risk of compressive optic neuropathy using orbital radiotherapy in patients with active thyroid eye disease.
    Shams PN; Ma R; Pickles T; Rootman J; Dolman PJ
    Am J Ophthalmol; 2014 Jun; 157(6):1299-305. PubMed ID: 24582992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orbital Radiotherapy Combined With Corticosteroid Treatment for Thyroid Eye Disease-Compressive Optic Neuropathy.
    Gold KG; Scofield S; Isaacson SR; Stewart MW; Kazim M
    Ophthalmic Plast Reconstr Surg; 2018; 34(2):172-177. PubMed ID: 29517594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orbital radiation for graves ophthalmopathy: a report by the American Academy of Ophthalmology.
    Bradley EA; Gower EW; Bradley DJ; Meyer DR; Cahill KV; Custer PL; Holck DE; Woog JJ
    Ophthalmology; 2008 Feb; 115(2):398-409. PubMed ID: 18082885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of corticosteroids and external beam radiation in the management of moderate to severe thyroid eye disease.
    Zoumalan CI; Cockerham KP; Turbin RE; Volpe NJ; Kazim M; Douglas RS; Feldon SE
    J Neuroophthalmol; 2007 Sep; 27(3):205-14. PubMed ID: 17895822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the Treatment of Thyroid Eye Disease Associated Extraocular Muscle Myopathy and Optic Neuropathy.
    Lu TJ; Amarikwa L; Sears CM; Kossler AL
    Curr Neurol Neurosci Rep; 2022 Jun; 22(6):313-325. PubMed ID: 35614367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orbital radiation therapy for Graves' ophthalmopathy: measuring clinical efficacy and impact.
    Hahn E; Laperriere N; Millar BA; Oestreicher J; McGowan H; Krema H; Gill H; DeAngelis D; Hurwitz J; Tucker N; Simpson R; Chung C
    Pract Radiat Oncol; 2014; 4(4):233-9. PubMed ID: 25012831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical orbital decompression for thyroid eye disease.
    Boboridis KG; Bunce C
    Cochrane Database Syst Rev; 2011 Dec; (12):CD007630. PubMed ID: 22161415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy for Active Thyroid Eye Disease.
    Godfrey KJ; Kazim M
    Ophthalmic Plast Reconstr Surg; 2018; 34(4S Suppl 1):S98-S104. PubMed ID: 29771752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid eye disease: therapy in the active phase.
    Bhatti MT; Dutton JJ
    J Neuroophthalmol; 2014 Jun; 34(2):186-97. PubMed ID: 24821102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral dysthyroid compressive optic neuropathy responsive to teprotumumab.
    Hwang CJ; Nichols EE; Chon BH; Perry JD
    Eur J Ophthalmol; 2022 May; 32(3):NP46-NP49. PubMed ID: 33525898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of combined orbital radiation and systemic steroids in the management of Graves' orbitopathy.
    Kim JW; Han SH; Son BJ; Rim TH; Keum KC; Yoon JS
    Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):991-8. PubMed ID: 26876240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dose orbital radiotherapy for thyroid eye disease.
    Li Yim JF; Sandinha T; Kerr JM; Ritchie D; Kemp EG
    Orbit; 2011 Dec; 30(6):269-74. PubMed ID: 22132844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of radiation therapy in the treatment of Graves' orbitopathy.
    Matthiesen C; Thompson JS; Thompson D; Farris B; Wilkes B; Ahmad S; Herman T; Bogardus C
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):117-23. PubMed ID: 21030157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of lateral and medial orbital decompression for the treatment of compressive optic neuropathy in thyroid eye disease.
    Choe CH; Cho RI; Elner VM
    Ophthalmic Plast Reconstr Surg; 2011; 27(1):4-11. PubMed ID: 20736873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins and thyroid eye disease (TED): a systematic review.
    Malboosbaf R; Maghsoomi Z; Emami Z; Khamseh ME; Azizi F
    Endocrine; 2024 Jul; 85(1):11-17. PubMed ID: 38194219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-Related Changes in the Clinical Phenotype of Compressive Optic Neuropathy in Thyroid Eye Disease.
    Campbell AA; Nanda T; Oropesa S; Kazim M
    Ophthalmic Plast Reconstr Surg; 2019; 35(3):238-242. PubMed ID: 30234838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular Hypertension, Glaucoma or Compressive Neuropathy in Patient with Active TED.
    Stoyanova NS; Konareva-Kostianeva MI; Mitkova-Hristova VT
    Folia Med (Plovdiv); 2020 Jun; 62(2):418-423. PubMed ID: 32666771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adalimumab as steroid-sparing treatment of inflammatory-stage thyroid eye disease.
    Ayabe R; Rootman DB; Hwang CJ; Ben-Artzi A; Goldberg R
    Ophthalmic Plast Reconstr Surg; 2014; 30(5):415-9. PubMed ID: 24978425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alemtuzumab-Induced Thyroid Eye Disease: A Comprehensive Case Series and Review of the Literature.
    Nirmalan A; Blecher N; Hyder S; Couch SM; Godfrey KJ; Stan MN; Bradley EA; Wagner LH; Tooley AA
    Ophthalmic Plast Reconstr Surg; 2023 Sep-Oct 01; 39(5):470-474. PubMed ID: 36893061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.